Gleevec Trial in Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

NCT00081926 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
112
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals